top of page


Algone DFW Interventional Pain to become first clinic in Texas to treat patients with the new Neurolyser XR non-invasive ablation for low back pain
Dr. Shamsideen Musa is pleased to announce that he will become the first physician and first medical practice in Texas to install the new Neurolyser XR and begin treating patients this coming Tuesday April 7th. “I am proud to be the first to bring this new revolutionary treatment to Texas. We at Algone DFW Interventional Pain like to be on the leading edge of medicine.” Media is welcome to attend and see the device and how it works. The Neurolyser XR uses HIFU, a non-invasiv

Shared FUSMobile
7 days ago
First ever Low Back Pain patient in USA to be treated with Non-Invasive Neurolyser XR at Carolina Pain Institute 3/9/26
https://www.einpresswire.com/article/897666180/first-ever-low-back-pain-patient-in-usa-to-be-treated-with-non-invasive-neurolyser-xr-at-carolina-pain-institute-3-9-26 WINSTON SALEM, NC, UNITED STATES, March 6, 2026 / EINPresswire.com / -- Carolina Pain Institute and Dr. Leonardo Kapural to Become First Clinic in USA to treat patients with Newly FDA Approved Non-Invasive Back Pain Treatment, Neurolyser XR, Media Welcome to attend. 3/9/26 at 8:00am EST Carolina Pain Institute

Shared FUSMobile
Mar 8


Neurolyser XR Now FDA Cleared for Sale in USA.
Revolutionary Non-invasive Needleless Procedure for Treating Low Back Pain ALPHARETTA, GA, UNITED STATES, November 17, 2025 / EINPresswire.com / -- FUSMobile , Inc. is proud to announce that it received De Novo marketing authorization (DEN250015) from the FDA to begin marketing and sales of the Neurolyser XR system for the non-invasive treatment of low back pain. The Neurolyser XR is a first-of-its-kind device that uses high-intensity focused ultrasound (HIFU) to non-invasiv

Shared FUSMobile
Nov 17, 2025


The Neurolyser Was Granted CE Mark
FUSMobile has announced that its Neurolyser XR device has been granted CE Mark for the treatment of lumbar zygapophyseal joints...

Shared FUSMobile
Oct 18, 2024


Sacroiliitis study opens in UVA
The first few participants have been enrolled in a new clinical trial investigating the safety and efficacy of using FUSMobile’s...

Shared FUSMobile
Oct 18, 2024


High Intensity Focused Ultrasound: A novel and non-invasive approach to target tumors
Use of High Intensity Focused Ultrasound (HIFU) has been lauded as an incredible therapeutic alternative for tumors, pain and other...

Shared FUSMobile
Jun 18, 2024
bottom of page
